Physiologic Insulin Therapy for the Management of Hyperglycemia in the Hospital
Completed
Conditions studied: Diabetes Mellitus, Type 2, Hyperglycemia
In brief
Many hospitals have begun giving insulin to nearly all patients with diabetes while they are in the hospital even if a patient does not use insulin at home. Controlling blood sugar with insulin when a patient is hospitalized is believed to reduce the risk of complications and death, but research has not demonstrated these benefits except in patients who are critically ill. The purpose of this study, therefore, is to evaluate whether such insulin therapy actually does reduce in-hospital complications, deaths, need for intensive care, or length of stay in the hospital.
Key facts
- Study ID
- NCT02868606
- Run by
- Winthrop University Hospital
- People needed
- 40391
- Starts
- 2015-07-01
- Expected to finish
- 2018-06-30
- Last updated by the study team
- 2019-06-04
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Type 2 diabetes
You may not qualify if…
- Pregnant
- Admitted directly to an intensive care unit
- Length of stay <2 days
Where it is running
- Winthrop-University Hospital — Mineola, New York, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.